Prestige Consumer Healthcare (PBH) Gains from Investment Securities (2010 - 2025)
Prestige Consumer Healthcare (PBH) recorded quarterly Gains from Investment Securities of $44000.0 in Q4 2025, down 98.78% quarter-over-quarter from $3.6 million in Q3 2025, and down 99.26% on a YoY basis from $5.9 million in Q4 2024.
Prestige Consumer Healthcare (PBH) Gains from Investment Securities (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Gains from Investment Securities history runs 16 years deep, the most recent figure standing at $44000.0 for Q4 2025.
- In Q4 2025, Gains from Investment Securities fell 99.26% year-over-year to $44000.0; the TTM figure through Dec 2025 stood at -$1.8 million (down 129.79% YoY), while the FY2025 annual figure was -$234000.0, changed N/A from the prior year.
- Gains from Investment Securities was $44000.0 for Q4 2025 at Prestige Consumer Healthcare, down from $3.6 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $5.9 million in Q4 2024 to a low of -$6.1 million in Q1 2025.
- Historically, Gains from Investment Securities has averaged $587052.6 across 5 years, with a median of $608000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities surged 6619.32% in 2023, then sank 2725.97% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at -$1.6 million in 2021, then jumped by 77.59% to -$353000.0 in 2022, then surged by 1111.05% to $3.6 million in 2023, then soared by 65.73% to $5.9 million in 2024, then sank by 99.26% to $44000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $44000.0 (Q4 2025), $3.6 million (Q3 2025), and $608000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Prestige Consumer Healthcare | 2.39 Bn | 2.33 Bn | 157.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44,000.00 |
| Dec 31, 2025 | 44,000.00 |
| Sep 30, 2025 | 3.61 Mn |
| Sep 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 608,000.00 |
| Jun 30, 2025 | 608,000.00 |
| Mar 31, 2025 | -6.07 Mn |
| Mar 31, 2025 | -6.07 Mn |
| Dec 31, 2024 | 5.92 Mn |
| Dec 31, 2024 | 5.92 Mn |
| Sep 30, 2024 | -1.06 Mn |
| Sep 30, 2024 | -1.06 Mn |
| Jun 30, 2024 | 978,000.00 |
| Jun 30, 2024 | 978,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Mar 31, 2024 | 231,000.00 |
| Dec 31, 2023 | 3.57 Mn |
| Dec 31, 2023 | 3.57 Mn |
| Sep 30, 2023 | -4.50 Mn |
| Sep 30, 2023 | -4.50 Mn |